The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Role of anti-oncomirs miR-143 and -145 in human colorectal tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. W., Au, G. K. H., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E., Hanson, E., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,021
Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain
Ma, J.-B., Ye, K., & Patel, D. J. (2004) · Nature · doi:10.1038/nature02519 · Cited by 732
Slaby, O., Svoboda, M., Fabian, P., Smerdova, T., Knoflickova, D., Bednarikova, M., Nenutil, R., & Vyzula, R. (2007) · Oncology · doi:10.1159/000113489 · Cited by 682
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
MicroRNA Biogenesis and Cancer
Gregory, R. I., & Shiekhattar, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0298 · Cited by 613
Role of miR-143 targeting KRAS in colorectal tumorigenesis
Chen, X., Guo, X., Zhang, H., Xiang, Y., Chen, J., Yin, Y., Cai, X., Wang, K., Wang, G., Ba, Y., et al. (2009) · Oncogene · doi:10.1038/onc.2008.474 · Cited by 549
Structure and conserved RNA binding of the PAZ domain
Yan, K. S., Yan, S., Farooq, A., Han, A., Zeng, L., & Zhou, M.-M. (2003) · Nature · doi:10.1038/nature02129 · Cited by 488
Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain
Lingel, A., Simon, B., Izaurralde, E., & Sattler, M. (2003) · Nature · doi:10.1038/nature02123 · Cited by 450
McManus, M. T. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00038-5 · Cited by 439
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
Takagi, T., Iio, A., Nakagawa, Y., Naoe, T., Tanigawa, N., & Akao, Y. (2009) · Oncology · doi:10.1159/000218166 · Cited by 287
Self-citationDownregulation of microRNAs‐143 and ‐145 in B‐cell malignancies
Akao, Y., Nakagawa, Y., Kitade, Y., Kinoshita, T., & Naoe, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00618.x · Cited by 285
Self-citationMicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers
Akao, Y., Nakagawa, Y., & Naoe, T. (2006) · Oncology Reports · doi:10.3892/or.16.4.845 · Cited by 275
Self-citationMicroRNA-143 and -145 in Colon Cancer
Akao, Y., Nakagawa, Y., & Naoe, T. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0550 · Cited by 220
Self-citationEder, M., & Scherr, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmcibr051201 · Cited by 117
Akao, Y., Itoh, T., Ohguchi, K., Iinuma, M., & Nozawa, Y. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.01.058 · Cited by 64
Self-citationShin, C. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)14000-3 · Cited by 44
Ueno, Y., Inoue, T., Yoshida, M., Yoshikawa, K., Shibata, A., Kitamura, Y., & Kitade, Y. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.086 · Cited by 27
Self-citationSynthesis and Properties of Nucleic Acid Analogues Consisting of a Benzene−Phosphate Backbone
Ueno, Y., Kato, T., Sato, K., Ito, Y., Yoshida, M., Inoue, T., Shibata, A., Ebihara, M., & Kitade, Y. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050635m · Cited by 20
Self-citation
Cited by
Di Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · doi:10.20944/preprints201810.0507.v1 · Cited by 605
Metadata
- Authors
- Akao, Y., Nakagawa, Y., Hirata, I., Iio, A., Itoh, T., Kojima, K., Nakashima, R., Kitade, Y., & Naoe, T.
- Venue
- Cancer Gene Therapy
- Published
- 2010-01-22
- Volume
- 17
- Issue
- 6
- Pages
- 398-408
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- OpenAlex
- W2090551514
- Cited by
- 262
- References
- 24
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.